Jia-horng H. Kao
Expertise in
8
conditions

Jia-horng H. Kao

Gastroenterology
7 Chung Shan South Road, 
TPQ, TW 
Expertise in
8
conditions
7 Chung Shan South Road, 
TPQ, TW 

Overview

Jia-horng Kao is a Gastroenterologist practicing medicine in Taiwan.

Mr. Kao is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Hepatitis, Hepatitis B, Hepatitis C, Hepato-Pancreato-Biliary Surgery, and Liver Transplant.

He is actively involved in clinical research, co-authoring 501 peer reviewed articles and participating in 5 clinical trials.

Specialties

Gastroenterology

Gender

Male

Locations

7 Chung Shan South Road, TPQ 10002, Taiwan
Other Locations
1 Chang Te Street, TPQ 10048, Taiwan
National Taiwan University Hospital Bei Hu Branch
TPQ, Taiwan
Yunlin Branch, Douliu, TNQ, Taiwan
7 Chung Shan South Road, 100, TPQ, Taiwan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

An Exploratory Study to Evaluate The Efficacy And Safety of HLX10, A Humanized Monoclonal Antibody Targeting Programmed Death-1 (PD-1) Protein In Chronic Hepatitis B Patients
An Exploratory Study to Evaluate The Efficacy And Safety of HLX10, A Humanized Monoclonal Antibody Targeting Programmed Death-1 (PD-1) Protein In Chronic Hepatitis B Patients
Enrollment Status: Unknown
Publish Date: October 20, 2020
Intervention Type: Drug
Study Drugs: Recombinant anti-programmed death-1 humanized monoclonal antibody, Nucleoside/Nucleotide analogues
Study Phase: Phase 2
A Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dose and Multiple Doses of GSK3389404 in Chronic Hepatitis B Subjects
A Double-Blind, Placebo-Controlled Study to Assess the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Ascending Dose and Multiple Doses of GSK3389404 in Chronic Hepatitis B Subjects
Enrollment Status: Completed
Publish Date: October 01, 2020
Intervention Type: Drug
Study Phase: Phase 2
A Phase 2, Randomized, Multiple-dose, Double-blind, Placebo-controlled Study of JKB-122 to Assess Liver Tests in HCV Subjects Who Have Been Nonresponsive to Prior Interferon Based Therapies Either Alone or in Combination With Ribavirin
A Phase 2, Randomized, Multiple-dose, Double-blind, Placebo-controlled Study of JKB-122 to Assess Liver Tests in HCV Subjects Who Have Been Nonresponsive to Prior Interferon Based Therapies Either Alone or in Combination With Ribavirin
Enrollment Status: Terminated
Publish Date: July 21, 2020
Intervention Type: Drug
Study Phase: Phase 2
Elbasvir/Grazoprevir for Treatment-naive and Treatment-experienced Patients With Hepatitis C Virus Genotype 1b Receiving Hemodialysis
Elbasvir/Grazoprevir for Treatment-naive and Treatment-experienced Patients With Hepatitis C Virus Genotype 1b Receiving Hemodialysis
Enrollment Status: Completed
Publish Date: March 11, 2020
Intervention Type: Drug
Study Phase: Phase 4
Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir for Treatment-Naive and Treatment-Experienced Non-Cirrhotic Patients With Hepatitis C Virus Genotype 1b Receiving Hemodialysis
Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir for Treatment-Naive and Treatment-Experienced Non-Cirrhotic Patients With Hepatitis C Virus Genotype 1b Receiving Hemodialysis
Enrollment Status: Completed
Publish Date: July 19, 2019
Intervention Type: Drug
Study Phase: Phase 4
View 4 Less Clinical Trials

501 Total Publications

Highlights.
Highlights.
Journal: Journal of the Formosan Medical Association = Taiwan yi zhi
Published: August 31, 2026

Frequently Asked Questions about Jia-horng H. Kao

Is Jia-horng H. Kao a top-rated expert for Hepatitis?

MediFind is an objective health platform that identifies experts based on real-world data. Jia-horng H. Kao is classified as an Elite expert for Hepatitis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Jia-horng H. Kao specialize in?

While Jia-horng H. Kao is a Gastroenterology, they have specific expertise in Hepatitis, Hepatitis B, and Hepatitis C. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Gastroenterology.

Does Jia-horng H. Kao participate in research or clinical trials?

Yes. Jia-horng H. Kao has published 501 articles and abstracts on conditions like Hepatitis. You can view a list of Jia-horng H. Kao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Kao's expertise for a condition
ConditionClose
View All 14 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile